Establishment of a patient-derived orthotopic osteosarcoma mouse model

[1]  I. Endo,et al.  Patient-derived orthotopic xenograft (PDOX) nude mouse model of soft-tissue sarcoma more closely mimics the patient behavior in contrast to the subcutaneous ectopic model. , 2015, Anticancer research.

[2]  P. Yuan,et al.  Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression , 2014, Oncogene.

[3]  S. Ghivizzani,et al.  Animal Models in Osteosarcoma , 2014, Front. Oncol..

[4]  E. Brega,et al.  Non-Small Cell Lung Carcinoma Biomarker Testing: The Pathologist’s Perspective , 2014, Front. Oncol..

[5]  Andrew J. Wagner.  Patient‐derived sarcoma xenografts for individual‐patient selection of chemotherapy—ready for prime time? , 2014, Cancer.

[6]  J. Nyman,et al.  Micro-Computed Tomography Derived Anisotropy Detects Tumor Provoked Deviations in Bone in an Orthotopic Osteosarcoma Murine Model , 2014, PloS one.

[7]  R. Lock,et al.  Stability of gene expression and epigenetic profiles highlights the utility of patient-derived paediatric acute lymphoblastic leukaemia xenografts for investigating molecular mechanisms of drug resistance , 2014, BMC Genomics.

[8]  I. Lewis,et al.  Osteosarcoma treatment - where do we stand? A state of the art review. , 2014, Cancer treatment reviews.

[9]  Marc Coram,et al.  Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition , 2014, Breast Cancer Research.

[10]  David Sidransky,et al.  Patient-derived xenografts for individualized care in advanced sarcoma , 2014, Cancer.

[11]  J. Sicklick,et al.  Generation of orthotopic patient-derived xenografts from gastrointestinal stromal tumor , 2014, Journal of Translational Medicine.

[12]  Yinglong Zhang,et al.  Tumor self-seeding by circulating tumor cells in nude mouse models of human osteosarcoma and a preliminary study of its mechanisms , 2014, Journal of Cancer Research and Clinical Oncology.

[13]  R. Maxwell,et al.  Development of a Preclinical Orthotopic Xenograft Model of Ewing Sarcoma and Other Human Malignant Bone Disease Using Advanced In Vivo Imaging , 2014, PloS one.

[14]  B. Fuchs,et al.  CXCR4 antibody treatment suppresses metastatic spread to the lung of intratibial human osteosarcoma xenografts in mice , 2014, Clinical & Experimental Metastasis.

[15]  B. Fuchs,et al.  Expression of the Chemokine Receptor CXCR7 in CXCR4-Expressing Human 143B Osteosarcoma Cells Enhances Lung Metastasis of Intratibial Xenografts in SCID Mice , 2013, PloS one.

[16]  M. Allen,et al.  A clinically relevant mouse model of canine osteosarcoma with spontaneous metastasis. , 2013, In vivo.

[17]  W. Weichert,et al.  Radiosensitization by histone deacetylase inhibition in an osteosarcoma mouse model , 2013, Strahlentherapie und Onkologie.

[18]  E. Kleinerman,et al.  Expression of c‐FLIP in pulmonary metastases in osteosarcoma patients and human xenografts , 2013, Pediatric blood & cancer.

[19]  S. Ferrari,et al.  The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models , 2013, Clinical Cancer Research.

[20]  S. Langdon.  Animal modeling of cancer pathology and studying tumor response to therapy. , 2012, Current drug targets.

[21]  J. Debus,et al.  Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation , 2012, Strahlentherapie und Onkologie.

[22]  J. Debus,et al.  Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines , 2011, Radiation oncology.

[23]  S. Orsulic,et al.  Mouse models of cancer. , 2011, Annual review of pathology.

[24]  M. Pawlita,et al.  High-throughput detection and multiplex identification of cell contaminations , 2009, Nucleic acids research.

[25]  K. Flatmark,et al.  Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status. , 2009, International journal of radiation oncology, biology, physics.

[26]  Axel Benner,et al.  Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  P. Choong,et al.  Osteosarcoma treatment: state of the art , 2009, Cancer and Metastasis Reviews.

[28]  S. Bielack,et al.  Current strategies of chemotherapy in osteosarcoma , 2006, International Orthopaedics.

[29]  P. Lichter,et al.  Detection of chromosomal imbalances in retinoblastoma by matrix‐based comparative genomic hybridization , 2005, Genes, chromosomes & cancer.

[30]  Shishir Shah,et al.  Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma , 2004, BMC Cancer.

[31]  H. Döhner,et al.  Matrix‐based comparative genomic hybridization: Biochips to screen for genomic imbalances , 1997, Genes, chromosomes & cancer.

[32]  P. Lichter,et al.  Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  L. Boquist,et al.  A novel spontaneous metastasis model of human osteosarcoma developed using orthotopic transplantation of intact tumor tissue into tibia of nude mice , 1997, Clinical & Experimental Metastasis.

[34]  G. Delling,et al.  [Determination of the degree of morphological regression following chemotherapy in malignant bone tumors]. , 1983, Der Pathologe.

[35]  C. Fletcher,et al.  WHO classification of tumours of soft tissue and bone , 2013 .

[36]  W. Winkelmann,et al.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.